NADMED was invited to the San Francisco Longevity Summit 2022, one of North America’s most important aging researchers’ gatherings. Over the two days along with the numerous presentations, NADMED CEO Jari Närhi had an opportunity to meet potential...
NADMED is attending this year’s Slush event 17.-18.11. with the University of Helsinki. You can find NADMED with Health Incubator Helsinki (area 18, stand E.10). NADMED is looking forward to exciting two days of meetings, mingling, networking and the famous...
NADMED was chosen among the best clinical laboratory services in Europe. The selection was made by one of the Europe’s leading health tech magazines Life Science Review. The magazine interviewed NADMED’s COO Jana Buzkova, who tells about the new standards...
The easy and reliable method that measures all NAD metabolites has also convinced financiers. NADMED recently completed its first financing round of half a million euros, led by deep tech fund Voima Ventures. Other investors include individuals and members of the...
NADMED raised a lot of interest among the VC investors at Nordic Life Science days 2022 in Malmö, Sweden. Investors were particularly enthusiastic about NADMED’s first three quarters’ business development. NADMED is currently growing rapidly selling...
